Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Deficit)
Beginning balance (in shares) at Dec. 31, 2018   27,949    
Beginning balance at Dec. 31, 2018 $ 29,533 $ 28 $ 38,797 $ (9,292)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Sale of Common stock and warrants, net of fees (in shares)   4,123    
Sale of Common stock and warrants, net of fees 12,644 $ 4 12,640  
Share based compensation 1,215   1,215  
Common stock issued upon warrant exercise (in shares)   1,758    
Common stock issued upon warrant exercise 1,300 $ 2 1,298  
Common stock issued upon exercise of options (in shares)   10    
Common stock issued upon exercise of options 6 $ 0 6  
Common stock issued upon cashless exercise of options (in shares)   506    
Common stock issued upon cashless exercise of options 0 $ 1 (1)  
Common stock issued in connection with business combinations (in shares)   970    
Common stock issued in connection with business combinations 3,625 $ 1 3,624  
Common stock issued upon conversion of convertible debt (in shares)   1,259    
Common stock issued upon conversion of convertible debt 2,405 $ 1 2,404  
Common stock issued for services (in shares)   203    
Common stock issued for services 549 $ 0 549  
Common stock issued for accrued share-based compensation (in shares)   100    
Common stock issued for accrued share-based compensation 210 $ 0 210  
Net income 1,322     1,322
Ending balance (in shares) at Dec. 31, 2019   36,878    
Ending balance at Dec. 31, 2019 52,809 $ 37 60,742 (7,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share based compensation 3,856   3,856  
Sale of common stock, net of fees (in shares)   14,375    
Sale of common stock, net of fees 207,134 $ 14 207,120  
Common stock issued upon warrant exercise (in shares)   1,370    
Common stock issued upon warrant exercise 3,842 $ 1 3,841  
Common stock issued upon cashless exercise of warrants (in shares)   918    
Common stock issued upon cashless exercise of warrants 0 $ 1 (1)  
Common stock issued upon exercise of options (in shares)   71    
Common stock issued upon exercise of options 230 $ 0 230  
Common stock issued upon cashless exercise of options (in shares)   694    
Common stock issued upon cashless exercise of options 0 $ 1 (1)  
Common stock issued in connection with business combinations (in shares)   1,730    
Common stock issued in connection with business combinations 39,147 $ 2 39,145  
Common stock issued for assets (in shares)   20    
Common stock issued for assets 136 $ 0 136  
Common stock issued for services (in shares)   50    
Common stock issued for services 0 $ 0 0  
Common stock issued for accrued payroll (in shares)   325    
Common stock issued for accrued payroll 717 $ 0 717  
Common stock issued for accrued share-based compensation (in shares)   729    
Common stock issued for accrued share-based compensation 3,798 $ 1 3,797  
Share based compensation, net of shares withheld for employee tax liability (in shares)   (8)    
Net income 5,328     5,328
Ending balance (in shares) at Dec. 31, 2020   57,152    
Ending balance at Dec. 31, 2020 316,997 $ 57 319,582 (2,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share based compensation 1,258   1,258  
Common stock issued upon warrant exercise (in shares)   256    
Common stock issued upon warrant exercise 335   335  
Common stock issued upon cashless exercise of warrants (in shares)   657    
Common stock issued upon cashless exercise of warrants   $ 1 (1)  
Common stock issued upon exercise of options (in shares)   469    
Common stock issued upon exercise of options 1,758 $ 1 1,757  
Common stock issued upon cashless exercise of options (in shares)   325    
Common stock issued in connection with business combinations (in shares)   807    
Common stock issued in connection with business combinations 37,272 $ 1 37,271  
Common stock issued in connection with purchase of intangible assets (in shares)   4    
Common stock issued in connection with purchase of intangible assets 168   168  
Common stock issued for services (in shares)   145    
Common stock issued for services 717   717  
Common stock redeemed in litigation settlement (in shares)   (90)    
Common stock issued for accrued share-based compensation (in shares)   204    
Net income 12,786     12,786
Ending balance (in shares) at Dec. 31, 2021   59,929    
Ending balance at Dec. 31, 2021 $ 371,291 $ 60 $ 361,087 $ 10,144